Abstract |
Pulmonary embolism remains a common and potentially life-threatening disease. For patients with intermediate- and high-risk pulmonary embolism, catheter-based revascularization therapy has emerged as potential alternative to systemic thrombolysis or surgical embolectomy. Ultrasound-assisted catheter-directed thrombolysis is a contemporary catheter-based technique and is the focus of the present review. Ultrasound-assisted catheter-directed thrombolysis is more effective in reversing right ventricular dysfunction and dilatation in comparison with anticoagulation alone in patients at intermediate risk. However, a direct comparison of ultrasound-assisted thrombolysis with systemic thrombolysis or surgical thrombectomy is not available. Ultrasound-assisted thrombolysis with initial intrapulmonary thrombolytic bolus may also be effective in high-risk patients, but evidence from randomized trials is not available. This review summarizes current data on ultrasound-assisted thrombolysis for acute pulmonary embolism.
|
Authors | Rolf P Engelberger, Nils Kucher |
Journal | European heart journal
(Eur Heart J)
Vol. 35
Issue 12
Pg. 758-64
(Mar 2014)
ISSN: 1522-9645 [Electronic] England |
PMID | 24497337
(Publication Type: Journal Article, Review, Systematic Review)
|
Chemical References |
- Fibrinolytic Agents
- Recombinant Proteins
- Tissue Plasminogen Activator
|
Topics |
- Acute Disease
- Catheterization
(methods)
- Combined Modality Therapy
- Fibrinolytic Agents
(administration & dosage)
- Humans
- Mechanical Thrombolysis
(methods)
- Pulmonary Embolism
(therapy)
- Randomized Controlled Trials as Topic
- Recombinant Proteins
(administration & dosage)
- Tissue Plasminogen Activator
(administration & dosage)
- Ultrasonography, Interventional
(methods)
|